Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians Health Study II Randomized Controlled Trial
JAMA, 12/12/08
Gaziano JM et al. – A large, long-term trial of male physicians shows that supplementation with neither vitamin E nor C reduced prostate or total cancer risk in middle-aged and older men.
Methods- Study of whether long-term vitamin E or C supplementation decreases risk of prostate and total cancer events among men
- Physicians' Health Study II: randomized, double-blind, placebo-controlled factorial trial of vitamins E and C from 1997-August 31, 2007
- Enrollment of 14,641 male US physicians initially age ≥50 ys, including 1307 men with history of prior cancer at entry
- Intervention: individual supplements; vitamin E (400 IU/every other day); vitamin C (500 mg/day)
- Main outcome measures: Prostate cancer and total cancer
- Mean follow-up of 8 yrs: 1008 confirmed incident cases of prostate cancer; 1943 total cancers
- No effect on prostate or total cancer incidence for vitamin E vs placebo
- No significant effect of vitamin C on prostate or total cancer
- Neither vitamin E nor vitamin C had a significant effect on colorectal, lung, or other site-specific cancers
- Findings remained after adjustment for adherence and exclusion of first 4 or 6 yrs of follow-up
- Stratification by cancer risk factors had no significant modification of effect of vitamin E on prostate cancer risk or either supplement on total cancer risk
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
Evidence-based Complementary and Alternative Medicine , 12/02/09
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Carcinogenesis, 12/01/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of urinary bladder cancer: a case-control analysis of industry and occupation
BMC Cancer, 12/20/09
Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas
Annals of Diagnostic Pathology, 12/20/09
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


